CYTARABINE - PWS 1GN/VIAL DIN 02167883
Status: Cancelled Post Market
Holder: NOVOPHARM LIMITED
Health Canada record
| Active ingredient(s) | CYTARABINE 1 G |
|---|
| Dosage form | Powder For Solution |
|---|
| Route | Intravenous; Intrathecal; Subcutaneous |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | L01BC01 CYTARABINE |
|---|
| Original market date | 31-Dec-1995 |
|---|
| Current status date | 26-Oct-2015 |
|---|
| Source | Health Canada DPD |
|---|
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CYTARABINE
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02515296 | CYTARABINE INJECTION | STERIMAX INC | Solution | CYTARABINE 100 MG | Marketed |
| 02126656 | CYTARABINE INJECTION | PFIZER CANADA ULC | Solution | CYTARABINE 100 MG | Marketed |
| 02403838 | CYTOSAR | PHARMASCIENCE INC | Solution | CYTARABINE 100 MG | Approved |
| 02403811 | CYTOSAR | PHARMASCIENCE INC | Solution | CYTARABINE 20 MG | Approved |
| 02406772 | PMS-CYTARABINE | PHARMASCIENCE INC | Solution | CYTARABINE 100 MG | Marketed |
| 02404397 | AJ-CYTARABINE | AGILA JAMP CANADA INC | Solution | CYTARABINE 100 MG | Cancelled Pre Market |
| 02167891 | CYTARABINE - PWS 2GM/VIAL | NOVOPHARM LIMITED | Powder For Solution | CYTARABINE 2 G | Cancelled Post Market |
| 02167875 | CYTARABINE - PWS 500MG/VIAL | NOVOPHARM LIMITED | Powder For Solution | CYTARABINE 500 MG | Cancelled Post Market |
| 00885797 | CYTARABINE INJ 100MG/ML | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | CYTARABINE 100 MG | Cancelled Post Market |
| 02394901 | CYTARABINE INJECTION BP | SANDOZ CANADA INCORPORATED | Solution | CYTARABINE 100 MG | Cancelled Pre Market |
| 02402203 | CYTARABINE INJECTION, MYLAN STD. | MYLAN PHARMACEUTICALS ULC | Solution | CYTARABINE 100 MG | Cancelled Pre Market |
| 02167867 | CYTARABINE-PWS 100MG/VIAL | NOVOPHARM LIMITED | Powder For Solution | CYTARABINE 100 MG | Cancelled Post Market |
| 00194727 | CYTOSAR | PHARMASCIENCE INC | Powder For Solution | CYTARABINE 500 MG | Cancelled Post Market |
| 00386715 | CYTOSAR | PHARMASCIENCE INC | Powder For Solution | CYTARABINE 100 MG | Cancelled Post Market |
| 00646296 | CYTOSAR | PHARMASCIENCE INC | Powder For Solution | CYTARABINE 1 G | Cancelled Post Market |
| 00646318 | CYTOSAR | PHARMASCIENCE INC | Powder For Solution | CYTARABINE 2 G | Cancelled Post Market |
| 02241150 | DEPOCYT | SKYEPHARMA INC. | Suspension | CYTARABINE 10 MG | Cancelled Post Market |
| 02406764 | PMS-CYTARABINE | PHARMASCIENCE INC | Solution | CYTARABINE 20 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 4960 | 1995-05-25 | New Drug Submission (NDS) | |
International API supply for CYTARABINE
4 valid EDQM Certificates of Suitability from 4 holders. 5 active FDA Drug Master Files.
Request a quote for CYTARABINE - PWS 1GN/VIAL
How to read a Canadian DIN record